Scarica l'app Stockscreener
8.29
1.34%
0.11
Dopo l'orario di chiusura:
8.50
0.21
+2.53%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché WVE Giù?
Forum
Previsione
Wave Life Sciences Ltd Borsa (WVE) Ultime notizie
Wave Life Sciences (NASDAQ:WVE) Pulls Back 14% This Week, but Still Delivers Shareholders Strong 37% CAGR Over 3 Years - 富途牛牛
Short interest data insights for Wave Life Sciences Ltd.Weekly Trading Summary & Weekly Stock Breakout Alerts - Newser
Risk adjusted return profile for Wave Life Sciences Ltd. analyzedWeekly Stock Recap & High Accuracy Trade Alerts - Newser
Published on: 2025-09-05 14:47:35 - Newser
Predicting Wave Life Sciences Ltd. trend using moving averages2025 Market Overview & Fast Moving Stock Trade Plans - Newser
B. Riley’s Strategic Acquisition of Wave Life Sciences: Capitalizing on Biotech Market Inefficiencies - AInvest
Using data tools to time your Wave Life Sciences Ltd. exitPortfolio Gains Summary & AI Optimized Trading Strategy Guides - Newser
Relative strength of Wave Life Sciences Ltd. in sector analysisJuly 2025 EndofMonth & Weekly Setup with High ROI Potential - Newser
Using Ichimoku Cloud for Wave Life Sciences Ltd. technicalsJuly 2025 Retail & Daily Stock Trend Reports - Newser
What indicators show strength in Wave Life Sciences Ltd.July 2025 Summary & Real-Time Stock Price Movement Reports - Newser
Should you hold or exit Wave Life Sciences Ltd. nowDay Trade & AI Enhanced Execution Alerts - Newser
What’s the analyst consensus on Wave Life Sciences Ltd.Bond Market & Real-Time Volume Analysis Alerts - خودرو بانک
What is Wave Life Sciences Ltd.’s market position2025 Valuation Update & Weekly High Conviction Ideas - خودرو بانک
Wave Life Sciences Ltd. shares fall 1.19% intraday after a special call presentation. - AInvest
What does recent volatility data suggest for Wave Life Sciences Ltd.Market Performance Summary & Proven Capital Preservation Tips - Newser
WVE: Wells Fargo Lowers Price Target to $18, Maintains Overweigh - GuruFocus
Will Wave Life Sciences Ltd. rebound enough to break evenProfit Target & Free High Return Stock Watch Alerts - Newser
Momentum divergence signals in Wave Life Sciences Ltd. chartWeekly Stock Report & Technical Analysis for Trade Confirmation - Newser
Why Wave Life Sciences Ltd. is moving todayQuarterly Portfolio Report & Daily Profit Focused Screening - Newser
Wave Life Sciences stock price target lowered to $16 at Jones Trading - Investing.com
WAVE Life Sciences stock maintains Outperform rating at Raymond James - Investing.com India
When is the best time to exit Wave Life Sciences Ltd.2025 Biggest Moves & Verified Entry Point Detection - Newser
Will breakout in Wave Life Sciences Ltd. lead to full recoveryWeekly Profit Analysis & Stock Portfolio Risk Management - Newser
Wave’s RNA editor gains proof of concept but not top positioning in AATD - BioCentury
Will earnings trigger a reversal in Wave Life Sciences Ltd.Weekly Trade Report & Community Consensus Picks - Newser
Wave Life says data are positive but stock wavers - BioWorld MedTech
Leerink Partners raises WAVE Life Sciences stock price target to $26 on AATD data - Investing.com
Assessing Wave Life Sciences' (WVE) RNA Editing Pipeline: Is the Stock Undervalued Amid Clinical Progress and Financial Challenges? - AInvest
WAVE Life Sciences stock maintains Outperform rating at Raymond James By Investing.com - Investing.com UK
Transcript : Wave Life Sciences Ltd.Special Call - MarketScreener
Why Is GSK Partner Wave Life Sciences Stock Trading Lower On Wednesday?WAVE Life Sciences (NASDAQ:WVE) - Benzinga
WVE: HC Wainwright & Co. Reiterates Buy Rating with $22 PT | WVE Stock News - GuruFocus
Wave Life Sciences Shares Drop Following WVE-006 Trial Update - MSN
Wave Life Sciences Says RNA-Editing Therapy Achieves 'Durable' Serum AAT Protein Production - MarketScreener
Wave Life Sciences stock tumbles after WVE-006 trial update - Investing.com
Why Is Wave Life Sciences Stock (WVE) Down 20% Today? - TipRanks
Wave Life Sciences reports promising data for AATD treatment - Investing.com
Wave Life Sciences reports promising data for AATD treatment By Investing.com - Investing.com Australia
Wave Life Sciences drops after trial data for GSK-partnered RNA-editing therapy - MSN
Wave Life Sciences drops after trial data for GSK-partnered RNA-editing therapy (WVE:NASDAQ) - Seeking Alpha
Wave Life Sciences Announces Positive Results for WVE-006 Study - TipRanks
Wave Life Sciences stock tumbles after WVE-006 trial update By Investing.com - Investing.com UK
Wave Life Sciences Announces Positive Update from Ongoing RestorAATion-2 Trial of WVE-006 in Alpha-1 Antitrypsin Deficiency - The Manila Times
Wave Life Sciences Announces Positive Update from Ongoing - GlobeNewswire
Breakthrough: First-Ever Restored AAT Production of 20.6µM Achieved in Wave's AATD Treatment Trial - Stock Titan
How institutional ownership impacts Wave Life Sciences Ltd. stock2025 Historical Comparison & Reliable Price Breakout Signals - Newser
Wave Life Sciences Ltd. stock daily chart insightsEarnings Risk Report & Fast Gain Stock Tips - Newser
What are analysts’ price targets for Wave Life Sciences Ltd.Weekly Profit Analysis & Weekly Watchlist for Hot Stocks - خودرو بانک
Is Wave Life Sciences Ltd.’s ROE strong enough2025 Momentum Check & Advanced Technical Analysis Signals - خودرو بانک
Published on: 2025-09-03 07:48:31 - خودرو بانک
Chart based analysis of Wave Life Sciences Ltd. trendsPrice Action & Free Technical Confirmation Trade Alerts - Newser
Intraday pattern recognizer results for Wave Life Sciences Ltd.July 2025 WrapUp & Fast Gain Stock Tips - Newser
1.40%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):